Atomoxetine for PTSD and executive function in veterans
Treatments studied
Part of Mental health clinical trials.
This trial tests if the medication atomoxetine can improve thinking and memory in veterans with PTSD and attention difficulties. It may help those who have not responded fully to other treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a veteran aged 18 to 75 with PTSD and attention problems.
- You have no major brain injury, glaucoma, or uncontrolled high blood pressure.
- You are not taking medications that interact with atomoxetine, such as certain antidepressants or stimulants.
- You have no history of schizophrenia, bipolar disorder, or recent substance abuse.
- You are not pregnant or planning to become pregnant during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether methylphenidate, a medication commonly used for attention issues, can help veterans with PTSD who also have memory or concentration problems. The goal is to see if it improves these cognitive symptoms.
This study tests whether a stimulant medication can help reduce PTSD symptoms. If you have PTSD and are generally healthy, you might be able to join.
This Phase 2 study tests whether reboxetine or methylphenidate can improve attention and emotional or sensory problems in adults with post-traumatic stress disorder (PTSD). You may be eligible if you have a confirmed PTSD diagnosis and are able to meet medication and safety requirements.
This study tests transcranial magnetic stimulation (TMS) as a treatment for PTSD in Veterans. TMS uses magnetic pulses to stimulate brain areas linked to PTSD, aiming to reduce symptoms without medication.
This study tests a new oral medication called PT150 to see if it helps reduce PTSD symptoms in Veterans. Participation involves taking the medication, regular check-ups, and questionnaires.
This trial studies whether a therapy focused on attention can reduce post-traumatic stress disorder (PTSD) symptoms. You may qualify if you have PTSD diagnosed by standard questionnaires and interviews, and if you can safely take part in the therapy sessions.
Hear when a new Posttraumatic Stress Disorder With Attention Defic trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.